SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-18-010701
Filing Date
2018-08-10
Accepted
2018-08-10 16:05:49
Documents
4
Period of Report
2018-09-27
Effectiveness Date
2018-08-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0818_soligenixinc.htm DEF 14A 555129
2 GRAPHIC image1.jpg GRAPHIC 87043
3 GRAPHIC image2.jpg GRAPHIC 194564
4 GRAPHIC image3.jpg GRAPHIC 182897
  Complete submission text file 0001213900-18-010701.txt   1196560
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 181008875
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1